Rep. Chris Collins, R-N.Y., is believed to have lost millions of dollars after a biotech firm’s stock tanked overnight following poor results in clinical trials.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.